Medica Sur Q2 net income drops 13% to MXN 117.73 million; revenue falls 3% to MXN 1.14 billion

• Médica Sur posted 2Q26 net income of MXN 117.73 million, down MXN 18 million from 2Q25 on lower volume of discharged inpatients.
• Revenue slipped 3% to MXN 1.14 billion, with higher activity in intermediate care, coronary unit, Gamma Knife, angiography, and MRI.
• EBITDA fell MXN 32 million to MXN 222 million, leaving the EBITDA margin steady at 19%.
• Cash rose 15% versus 2Q25 to MXN 1.58 billion; total debt was MXN 1 billion from MEDICA 25X and MEDICA 25-2X certificados bursátiles.
• Management flagged a temporary hit to insured-patient volumes from Mexico’s 2026 VAT credit changes for insurers, while expanding services in endocrinology/weight control and Alzheimer’s care.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medica Sur SAB de CV published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.